Possible scenario
Safety Setback Returns
18% Chance
The record is overshadowed by renewed implant reliability concerns, echoing the 2024 thread retraction issue. Regulators do not necessarily shut the program down, but they demand more evidence before Neuralink can scale enrollment.
Secondary impacts
- Healthcare -0.5%
Portfolio impact
S&P 500-0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.